Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
Conditions
Diffuse Large B-Cell Lymphoma · High-grade B-cell Lymphoma (HGBCL) · B-Cell Lymphoma Treatment · Relapsed or Refractory Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, ALESSANDRIA, Italy
Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, BO, Italy
Azienda Sanitaria Ospedaliera Santa Croce e Carle di Cuneo, Cuneo, Cuneo, Italy
Ospedale San Raffaele, Milan, MILANO, Italy
Istituto Nazionale dei Tumori, Milan, MILANO, Italy
Contact: Study coordinator (Paolo Corradini) · paolo.corradini@istitutotumori.mi.it · +39 02 23903408Irccs Istituto Clinico Humanitas, Rozzano, MILANO, Italy
Contact: Study coordinator (Carmelo Carlo-Stella) · carmelo.carlostella@hunimed.eu · +39 02 8224 4577AOU Policlinico Umberto I, Roma, RO, Italy